Millennium Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-683,381
| Closed | -$12.3M | – | 5054 |
|
|
2020
Q2 | $12.3M | Buy |
683,381
+281,268
| +70% | +$3.91M | 0.02% | 1069 |
|
|
2020
Q1 | $2.87M | Buy |
402,113
+305,344
| +316% | +$3.81M | 0.01% | 1764 |
|
|
2019
Q4 | $2.31M | Sell |
96,769
-24,018
| -20% | -$663K | ﹤0.01% | 2526 |
|
|
2019
Q3 | $3.24M | Buy |
120,787
+108,849
| +912% | +$3.06M | 0.01% | 2121 |
|
|
2019
Q2 | $324K | Sell |
11,938
-61,234
| -84% | -$1.92M | ﹤0.01% | 3503 |
|
|
2019
Q1 | $2.54M | Buy |
+73,172
| New | +$2.11M | ﹤0.01% | 2248 |
|
|
2018
Q4 | – | Sell |
-176,916
| Closed | -$4.71M | – | 4399 |
|
|
2018
Q3 | $4.71M | Buy |
+176,916
| New | +$5.78M | 0.01% | 1846 |
|
|
2018
Q2 | – | Sell |
-27,959
| Closed | -$913K | – | 4364 |
|
|
2018
Q1 | $913K | Buy |
27,959
+17,658
| +171% | +$775K | ﹤0.01% | 2738 |
|
|
2017
Q4 | $501K | Sell |
10,301
-433,281
| -98% | -$21.9M | ﹤0.01% | 3093 |
|
|
2017
Q3 | $24M | Buy |
443,582
+192,641
| +77% | +$11.3M | 0.04% | 687 |
|
|
2017
Q2 | $14.1M | Sell |
250,941
-4,249
| -2% | -$170K | 0.03% | 855 |
|
|
2017
Q1 | $10M | Sell |
255,190
-877,089
| -77% | -$27.9M | 0.02% | 1025 |
|
|
2016
Q4 | $25.4M | Buy |
1,132,279
+616,523
| +120% | +$12M | 0.05% | 498 |
|
|
2016
Q3 | $11.7M | Sell |
515,756
-430,513
| -45% | -$10.1M | 0.02% | 847 |
|
|
2016
Q2 | $22.3M | Buy |
946,269
+449,714
| +91% | +$11.1M | 0.05% | 478 |
|
|
2016
Q1 | $10.1M | Sell |
496,555
-1,151,427
| -70% | -$36.5M | 0.03% | 824 |
|
|
2015
Q4 | $84.8M | Buy |
1,647,982
+589,667
| +56% | +$28.6M | 0.18% | 94 |
|
|
2015
Q3 | $45.1M | Buy |
1,058,315
+637,956
| +152% | +$30.8M | 0.09% | 269 |
|
|
2015
Q2 | $19.1M | Sell |
420,359
-287,310
| -41% | -$11.6M | 0.04% | 653 |
|
|
2015
Q1 | $26.9M | Buy |
707,669
+344,878
| +95% | +$11.8M | 0.05% | 513 |
|
|
2014
Q4 | $10.3M | Sell |
362,791
-113,985
| -24% | -$3.17M | 0.02% | 972 |
|
|
2014
Q3 | $12.1M | Buy |
476,776
+313,198
| +191% | +$8.25M | 0.03% | 768 |
|
|
2014
Q2 | $4.77M | Sell |
163,578
-43,009
| -21% | -$1.04M | 0.01% | 1248 |
|
|
2014
Q1 | $5.35M | Buy |
206,587
+185,847
| +896% | +$4.96M | 0.02% | 1175 |
|
|
2013
Q4 | $534K | Sell |
20,740
-133,358
| -87% | -$3.24M | ﹤0.01% | 2677 |
|
|
2013
Q3 | $4.12M | Sell |
154,098
-47,025
| -23% | -$1.12M | 0.01% | 1231 |
|
|
2013
Q2 | $4.94M | Buy |
+201,123
| New | +$4M | 0.02% | 1028 |
|
Millennium Management's PTLA Position: Q3 2020 in Review
Millennium Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 683,381 shares — an estimated $12.3M sold.
Millennium Management first reported a position in PTLA in Q2 2013 and held it in 27 quarters. The position peaked at $84.8M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Millennium Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Millennium Management sold 683,381 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $12.3M.
- Millennium Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
- Millennium Management's Portola Pharmaceuticals, Inc. position peaked at $84.8M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.